EACR

envie a um amigo share this

EACR Conference Series 2016 - A Matter of Life or Death: Mechanisms and Relevance of Cell Death for Cancer Biology and Treatment

Rode Hoed’s Great Hall, Amsterdam, The Netherlands

 

28 - 30 January 2016

 

See more informations here: http://www.eacr.org/lifeordeath/index.php

3rd EACR-Sponsored Anticancer Agent Development Congress

Dokuz Eylül University, Medical Faculty Congress Center, Inciralti, Izmir, Turkey

 

18 - 19 May, 2015

 

See more informations here: http://www.cancerresearch2015.org/

3rd EACR-Sponsored Anticancer Agent Development Congress

Dokuz Eylül University, Medical Faculty Congress Center, Inciralti, Izmir, Turkey

 

18 - 19 May, 2015

 

See more informations here: http://www.cancerresearch2015.org/

2nd Special Conference on Cancer Genomics

Churchill College, Cambridge, United Kingdom

 

28 June-01 July, 2015

 

See more informations here: http://www.eacr.org/cancergenomics2015/index.php

2nd Special Conference on Cancer Genomics

Churchill College, Cambridge, United Kingdom

 

28 June-01 July, 2015

 

See more informations here: http://www.eacr.org/cancergenomics2015/index.php

Anticancer Drug Action and Drug Resistance: from Cancer Biology to the Clinic

Firenze Fiera, Florence, Italy

 

20-23 June, 2915

 

See more informations here: http://www.ecco-org.eu/Events/EAS2015
 

Anticancer Drug Action and Drug Resistance: from Cancer Biology to the Clinic

Firenze Fiera, Florence, Italy

 

20-23 June, 2915

 

See more informations here: http://www.ecco-org.eu/Events/EAS2015
 

Position paper on behalf of the European Association for Cancer Research

Professors Carlos Caldas and Yosef Yarden recently wrote a position paper on the behalf of the European Association for Cancer Research, which was published in the European Journal of Cancer (EJC). It describes the irreplaceable leading role of basic research in the future of cancer therapy, and how allocating resources to basic research could be the key to unlocking new achievements in personalized cancer treatment. 

 

Position paper on behalf of the European Association for Cancer Research

Professors Carlos Caldas and Yosef Yarden recently wrote a position paper on the behalf of the European Association for Cancer Research, which was published in the European Journal of Cancer (EJC). It describes the irreplaceable leading role of basic research in the future of cancer therapy, and how allocating resources to basic research could be the key to unlocking new achievements in personalized cancer treatment. 

 

2nd Anticancer Agents Congress:Targeting Cancer Stem Cells

Kervansaray Bodrum Resort Hotel, Bodrum, Turkey

 

23 – 27 April, 2014 

 

See more informations here: http://www.cancerresearch2014.org/